Is there any use of the interactive platform to speculate on the company’s stock price?Jiu’an Medical Secretary Wu Tong responded: there is no deliberately driving up the stock price_ 东方 Fortune Network

Recently,Jiu’an Medical(002432)announcementAccording to the report, the subsidiary New Crown Antigen home self-test OTC kit has been authorized by the US FDA EUA. After obtaining the U.S. Emergency Use Authorization (EUA), the product can be sold in the U.S. and countries/regions that recognize the U.S. EUA during the U.S. public health emergency. also,Jiu’an MedicalReplied on the Shenzhen Stock Exchange Interactive Yi platform that the company’s new crown antigen home self-test OTC kit products have been sold locally to the C-end and B-end by its subsidiary iHealth America at the beginning of last week. The company is actively approaching and following up with all customers. Orders.The release of related information detonatedJiu’an MedicalFor the stock price, the company has received 8 consecutive daily limit. Is there any situation where the company uses the Interactive Easy platform to cater to market hotspots and speculate on the company’s stock price? On November 24th, Jiu’an Medical Secretary Wu Tong said in an interview with a reporter from Beijing Business Daily that the information we disclosed on Interactive Easy is the information that has been publicized in the announcement or on the FDA website. We have no information other than this information. Other information has been disclosed, and there is no deliberately driving up or speculating on the stock price.

(Source: Beijing Commercial Daily)

Article source: Beijing Commercial Daily

Editor in charge: 3

Original title: Is there any use of the interactive platform to speculate the company’s stock price?Jiu’an Medical Secretary Wu Tong responded: there is no deliberately driving up the stock price